Presenting a sham treatment as personalised increases the placebo effect in a randomised controlled trial
Background: Tailoring interventions to patient subgroups can improve intervention outcomes for various conditions. However, it is unclear how much of this improvement is due to the pharmacological personalisation versus the non-specific effects of the contextual factors involved in the tailoring pro...
Main Authors: | Dasha A Sandra, Jay A Olson, Ellen J Langer, Mathieu Roy |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2023-07-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/84691 |
Similar Items
-
Prospects for the Management of Sepsis in an Era of Personalised Medicine
by: Jonathan Cohen
Published: (2019-03-01) -
From Personalized Medicine to Precision Psychiatry?
by: Češková E, et al.
Published: (2021-12-01) -
Super Placebos: A Feasibility Study Combining Contextual Factors to Promote Placebo Effects
by: Jay A. Olson, et al.
Published: (2021-03-01) -
Biomarkers for personalised prevention of chronic diseases: a common protocol for three rapid scoping reviews
by: E Plans-Beriso, et al.
Published: (2024-06-01) -
Can learning health systems help organisations deliver personalised care?
by: Bright I. Nwaru, et al.
Published: (2017-10-01)